J01FF01 • clindamycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins | Lincosamides
Clindamycin is an antibiotic used to treat a wide range of bacterial infections, including skin, bone, joint, and respiratory tract infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.
The medication is available in the form of capsules, injectable solutions, or topical gels, depending on the type and severity of the infection. It is important to follow your doctor's instructions and complete the full course of treatment to prevent the development of bacterial resistance.
Side effects may include nausea, diarrhea, abdominal pain, or skin rashes. In rare cases, clindamycin use may lead to pseudomembranous colitis, a serious condition requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of clindamycin.
Substance: clindamycin
Date of last drug list: 01-09-2023
Commercial code: W69708001
Concentration: 150mg / ml
Pharmaceutical form: solution for injection / infusion
Quantity: 1
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA
Holder: NORIDEM ENTERPRISES LIMITED - CIPRU
Number: 15074/2023/01
Shelf life: 1 year-after packing for marketing